Gyre Therapeutics (GYRE) Non-Current Debt (2010 - 2014)

Gyre Therapeutics (GYRE) has 5 years of Non-Current Debt data on file, last reported at $142000.0 in Q1 2014.

• Non-Current Debt for Q1 2014 came in at $142000.0, down 84.53% year-over-year; the trailing twelve-month figure through Mar 2014 was $142000.0 (down 84.53% YoY), and the FY2013 annual result was $283000.0, down 75.09% from the prior year.
• Non-Current Debt slipped to $142000.0 in Q1 2014 per GYRE's latest filing, from $283000.0 in the prior quarter.
• Over five years, Non-Current Debt peaked at $2.4 million in Q2 2011 and troughed at $142000.0 in Q1 2014.
• A 5-year average of $1.3 million and a median of $1.3 million in 2010 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2011 and 2014: Non-Current Debt jumped 47.22% in 2011, then plunged 84.53% in 2014.
• A 5-year view of Non-Current Debt shows it stood at $1.3 million in 2010, then jumped by 47.22% to $2.0 million in 2011, then sank by 42.8% to $1.1 million in 2012, then tumbled by 75.09% to $283000.0 in 2013, then plunged by 49.82% to $142000.0 in 2014.
• Business Quant data shows GYRE's Non-Current Debt at $142000.0 in Q1 2014, $283000.0 in Q4 2013, and $478000.0 in Q3 2013.